Redwood City, CA, United States of America

Steven R Schow

This inventor holds 29 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Telik, Inc., Cv Therapeutics, Inc., Verrica Pharmaceuticals Inc.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven R Schow. Retrieved from https://idiyas.com/inventor/steven-r-schow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 4)

% Patents Active = 51.7

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.9

ph-index = 9

Forward Citations = 374(Granted Patents)

Location History:

Redwood Shores, CA (US) (2002 - 2006)
Redwood Ciy, CA (US) (2006)
Redwood City, CA (US) (1998 - 2023)

Company Filing History:

Cv Therapeutics, Inc.

patents

3 out of 10

Verrica Pharmaceuticals Inc.

patents

4. 2 out of 5,512

Leland Stanford Junior University

patents

5. 1 out of 834,513

Other

patents

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Phospholipid Synthesis

Cantharidin

Tablet Formulation

Cyclin Dependent Kinase

Glucose Uptake Enhancers

Proteasome Inhibitors

Insulin Receptor Activators

Antitumor Agents

Therapeutic Compositions

Peptide Sulfones

Bioactive Derivatives

Naphthalene Ureas

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12540115 - Inhibitors of phospholipid synthesis and methods of use (2026-02-03),

2. 12221452 - Synthesis of cantharidin (2025-02-11),

3. 11702394 - Inhibitors of phospholipid synthesis and methods of use (2023-07-18),

4. 11168091 - Quantification and preparation of pharmaceutical grade cantharidin (2021-11-09),

5. 10745413 - Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives (2020-08-18),

6. 8361971 - Tablet formulation of ezatiostat (2013-01-29),

7. 8334266 - Process for and intermediates in the preparation of canfosfamide and its salts (2012-12-18),

8. 8198247 - Process for and intermediates in the preparation of canfosfamide and its salts (2012-06-12),

9. 8093231 - Sulfonylethyl phosphorodiamidates (2012-01-10),

10. 7262182 - Sulfonylethyl phosphorodiamidates (2007-08-28),

11. 7192918 - Tripeptide and tetrapeptide sulfones (2007-03-20),

12. 7129215 - Tripeptide and tetrapeptide thioethers (2006-10-31),

13. 7109330 - Purine inhibitors of cyclin dependent kinase 2 and IκB-α (2006-09-19),

14. 7071231 - Naphthalene ureas as glucose uptake enhancers (2006-07-04),

15. 7029695 - Therapeutic compositions containing glutathione analogs (2006-04-18),

Title: The Innovative Journey of Steven R. Schow

Introduction: Steven R. Schow is a pioneering inventor based in Redwood City, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Steven R. Schow holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Steven R. Schow has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Steven R. Schow has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and creativity that has led to numerous successful projects and inventions.

Conclusion: Steven R. Schow's relentless pursuit of innovation and his passion for pushing the limits of technology make him a true visionary in the world of inventions. His work continues to inspire and shape the future of technological advancements globally.

Profile summary based on public USPTO records.